Literature DB >> 24249702

Time trends in the characteristics of patients undergoing primary total knee arthroplasty.

Jasvinder A Singh1, David G Lewallen.   

Abstract

OBJECTIVE: To study the time trends in sociodemographic and clinical characteristics of patients undergoing primary total knee arthroplasty (TKA).
METHODS: We used the Mayo Clinic Total Joint Registry to examine the time trends in patient demographics (body mass index [BMI] and age), underlying diagnosis, medical (Deyo-Charlson Index) and psychological comorbidity (anxiety and depression), and examination findings of primary TKA patients from 1993-2005. We used the chi-square test and analysis of variance.
RESULTS: In total, 7,229 patients constituted the primary TKA cohort; 55% were women. The mean age decreased by 1.3 years (69.3 to 68.0 years), mean BMI increased by 1.7 kg/m(2) (30.1 to 31.8 kg/m(2) ), and mean Deyo-Charlson Index increased by 36% (1.1 to 1.5) over the 13-year study period (P ≤ 0.001 for all). Compared with 1993-1995, significantly more patients (by 2-3 times) in 2002-2005 had a BMI ≥40 kg/m(2) (4.8% versus 10.6%), age <50 years (2.9% versus 5.2%), Deyo-Charlson Index of ≥3 (12% versus 22.3%), depression (4.1% versus 14.8%), and anxiety (4.1% versus 8.9%), and significantly fewer patients had an underlying diagnosis of rheumatoid/inflammatory arthritis (6.4% versus 1.5%; P < 0.001 for all). Compared with 1993-1995, significant reductions were noted in 2002-2005 for the physical examination findings of anteroposterior knee instability, mediolateral knee instability, moderate to severe knee synovitis, severe limp, fair or poor muscle strength, and absent peripheral pulses (P ≤ 0.001 for all).
CONCLUSION: In this large US total joint registry study, we found significant time trends in patient characteristics, diagnosis, comorbidity, and knee/extremity examination findings in primary TKA patients over 13 years. These secular trends should be taken into account when comparing outcomes over time and in policy-making decisions.
Copyright © 2014 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2014        PMID: 24249702      PMCID: PMC4151514          DOI: 10.1002/acr.22233

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  52 in total

1.  The continuing epidemic of obesity in the United States.

Authors:  A H Mokdad; M K Serdula; W H Dietz; B A Bowman; J S Marks; J P Koplan
Journal:  JAMA       Date:  2000-10-04       Impact factor: 56.272

2.  The effects of the DRG-based prospective payment system on quality of care for hospitalized Medicare patients. An introduction to the series.

Authors:  K L Kahn; L V Rubenstein; D Draper; J Kosecoff; W H Rogers; E B Keeler; R H Brook
Journal:  JAMA       Date:  1990-10-17       Impact factor: 56.272

3.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Authors:  R A Deyo; D C Cherkin; M A Ciol
Journal:  J Clin Epidemiol       Date:  1992-06       Impact factor: 6.437

4.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2000

5.  The spread of the obesity epidemic in the United States, 1991-1998.

Authors:  A H Mokdad; M K Serdula; W H Dietz; B A Bowman; J S Marks; J P Koplan
Journal:  JAMA       Date:  1999-10-27       Impact factor: 56.272

6.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

7.  Morbidity during hospitalization: can we predict it?

Authors:  M E Charlson; F L Sax; C R MacKenzie; R L Braham; S D Fields; R G Douglas
Journal:  J Chronic Dis       Date:  1987

Review 8.  Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature.

Authors:  Olivier Ethgen; Olivier Bruyère; Florent Richy; Charles Dardennes; Jean-Yves Reginster
Journal:  J Bone Joint Surg Am       Date:  2004-05       Impact factor: 5.284

9.  Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.

Authors:  J R O'Dell; C E Haire; N Erikson; W Drymalski; W Palmer; P J Eckhoff; V Garwood; P Maloley; L W Klassen; S Wees; H Klein; G F Moore
Journal:  N Engl J Med       Date:  1996-05-16       Impact factor: 91.245

10.  The importance of patient expectations in predicting functional outcomes after total joint arthroplasty.

Authors:  Nizar N Mahomed; Matthew H Liang; Earl F Cook; Lawren H Daltroy; Paul R Fortin; Anne H Fossel; Jeffrey N Katz
Journal:  J Rheumatol       Date:  2002-06       Impact factor: 4.666

View more
  20 in total

1.  Effect of weight-loss diets prior to elective surgery on postoperative outcomes in obesity: A systematic review and meta-analysis.

Authors:  Natalie Pavlovic; Robert A Boland; Bernadette Brady; Furkan Genel; Ian A Harris; Victoria M Flood; Justine M Naylor
Journal:  Clin Obes       Date:  2021-08-31

2.  Does Education Level Mitigate the Effect of Poverty on Total Knee Arthroplasty Outcomes?

Authors:  Susan M Goodman; Lisa A Mandl; Bella Mehta; Iris Navarro-Millan; Linda A Russell; Michael L Parks; Shirin A Dey; Daisy Crego; Mark P Figgie; Joseph T Nguyen; Jackie Szymonifka; Meng Zhang; Anne R Bass
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-04-12       Impact factor: 4.794

3.  The association of comorbid conditions with patient-reported outcomes in Veterans with hip and knee osteoarthritis.

Authors:  Leah L Zullig; Hayden B Bosworth; Amy S Jeffreys; Leonor Corsino; Cynthia J Coffman; Eugene Z Oddone; William S Yancy; Kelli D Allen
Journal:  Clin Rheumatol       Date:  2014-06-12       Impact factor: 2.980

4.  Osteochondritis Dissecans in the Knee of Skeletally Immature Patients: Rates of Persistent Pain, Osteoarthritis, and Arthroplasty at Mean 14-Years' Follow-Up.

Authors:  Mario Hevesi; Thomas L Sanders; Ayoosh Pareek; Todd A Milbrandt; Bruce A Levy; Michael J Stuart; Daniel B F Saris; Aaron J Krych
Journal:  Cartilage       Date:  2018-07-12       Impact factor: 4.634

5.  Relationships among pain intensity, pain-related distress, and psychological distress in pre-surgical total knee arthroplasty patients: a secondary analysis.

Authors:  Katherine Hadlandsmyth; Edin Sabic; M Bridget Zimmerman; Kathleen A Sluka; Keela A Herr; Charles R Clark; Nicolas O Noiseux; John J Callaghan; Katharine M Geasland; Jennie L Embree; Barbara A Rakel
Journal:  Psychol Health Med       Date:  2016-05-24       Impact factor: 2.423

6.  A Novel Mobile Phone Text Messaging Platform Improves Collection of Patient-Reported Post-operative Pain and Opioid Use Following Orthopedic Surgery.

Authors:  Ajay Premkumar; Francis C Lovecchio; Jeffrey G Stepan; Cynthia A Kahlenberg; Jason L Blevins; Todd J Albert; Michael B Cross
Journal:  HSS J       Date:  2018-10-22

7.  Examination of exclusion criteria in total knee arthroplasty rehabilitation trials: influence on the application of evidence in day-to-day practice.

Authors:  Andrew J Kittelson; Brian J Loyd; Jeremy Graber; Michael A Himawan; Dawn Waugh; Jacqueline Davenport; Thomas J Hoogeboom; Jennifer Stevens-Lapsley
Journal:  J Eval Clin Pract       Date:  2021-03-24       Impact factor: 2.431

8.  Increasing obesity and comorbidity in patients undergoing primary total hip arthroplasty in the U.S.: a 13-year study of time trends.

Authors:  Jasvinder A Singh; David G Lewallen
Journal:  BMC Musculoskelet Disord       Date:  2014-12-17       Impact factor: 2.362

9.  The incidence of late prosthetic joint infections: a registry-based study of 112,708 primary hip and knee replacements.

Authors:  Kaisa Huotari; Mikko Peltola; Esa Jämsen
Journal:  Acta Orthop       Date:  2015-03-27       Impact factor: 3.717

10.  Racial disparities in total ankle arthroplasty utilization and outcomes.

Authors:  Jasvinder A Singh; Rekha Ramachandran
Journal:  Arthritis Res Ther       Date:  2015-03-21       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.